PharmaVentures Acts as Advisor and Broker to Dr Reddy’s to Identify and Secure Product Marketing Opportunities for the Russian/CIS Market

OXFORD, England, October 26, 2010 – PharmaVentures Ltd announced today that it had acted as the advisor and
broker to the Indian pharmaceutical company Dr Reddy's Laboratories in its
successful marketing and distribution agreement with the UK healthcare
company Vitabiotics Ltd for a range of nutraceutical products. The agreement
provides Dr Reddy's exclusive marketing rights in the Russian/CIS [..] Read the original article: here.

Shire Receives INTUNIV(TM) Paragraph IV Notice Letter

Watson is the Fourth Paragraph IV Filer Against INTUNIV
DUBLIN, October 26, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces that it has received a Paragraph IV
Notice Letter from Watson Laboratories, Inc. ("Watson") advising of the
filing of an Abbreviated New Drug Application ("ANDA") for a generic version
of Shire's 4 mg … Read the original article on Gaea Times at : Shire Receives INTUNIV(TM) Paragraph IV Notice Letter.

Bupa Report Reveals That Half of all UK Parents Send Children To School When Ill

LONDON, October 26, 2010 – Bupa has revealed that fever, diarrhoea or vomiting are not enough to
stop British parents sending their offspring to school. New research from the
Bupa 'How Are You Britain?' report reveals half of all parents in the UK
admit to sending their children to school or nursery when they are feeling
poorly and … Read more »».

Sirius Genomics Announces Issuance of U.S. Patent

VANCOUVER, October 26, 2010 – Sirius Genomics, a developer of companion diagnostics, announced today
that U.S. Patent No. 7,820,376 entitled "Protein C Polymorphisms" has been
issued by the United States Patent and Trademark Office. The patent relates
to a novel use of a Single Nucleotide Polymorphism (SNP) located in the
Protein C gene.

"The patent …. Original source  : Sirius Genomics Announces Issuance of U.S. Patent.